- NEWSTARGET - Ethan Huff - APRIL 12, 2023 -
The corporate-controlled media is leaping with joy over a new range of “vaccines” for conditions like cancer and heart disease that the pharmaceutical industry has slated to unleash by the year 2030.
None other than Moderna, which had never successfully produced a single vaccine before being chosen by the Trump administration for inclusion in the Operation Warp Speed covid “vaccine” scam, is promising to release a slate of new messenger RNA (mRNA) injections for everything from cancer and cardiovascular disease to autoimmune disease and RSV (respiratory syncytial virus).
The experimental shots are already showing “tremendous promise,” the company claims. What would have normally taken around 15 years to produce has been “unspooled” to just 12-18 months, said Moderna chief medical officer Dr. Paul Burton.
Thanks to Trump’s inclusion of the Moderna mRNA shot in Operation Warp Speed, the multi-billion-dollar company can now unleash all sorts of other new jabs on the same fast-tracked schedule. In as little as five years, Burton says, Moderna will have the ability to unleash new jabs for “all sorts of disease areas.”
“We will have that vaccine and it will be highly effective, and it will save many hundreds of thousands, if not millions of lives,” Burton claims. “I think we will be able to offer personalized cancer vaccines against multiple different tumor types to people around the world.”
(Related: Remember when GlaxoSmithKline [GSK] tried, but failed, to create and unleash a cancer vaccine back in 2013?)
Moderna planning to unleash a multivalent mRNA jab for covid, the flu, and RSV – all in one just like MMR (measles, mumps, and rubella)
Many rare diseases for which there are currently no viable, FDA-approved pharmaceuticals are targets for the Moderna mRNA “vaccine” pipeline.
“I think we will have mRNA-based therapies for rare diseases that were previously undruggable,” Burton says.
“And I think that 10 years from now, we will be approaching a world where you truly can identify the genetic cause of a disease and, with relative simplicity, go and edit that out and repair it using mRNA-based technology.”